1. Home
  2. SRTA vs VALN Comparison

SRTA vs VALN Comparison

Compare SRTA & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

HOLD

Current Price

$5.38

Market Cap

530.4M

Sector

N/A

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.62

Market Cap

495.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTA
VALN
Founded
2014
2012
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
530.4M
495.5M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
SRTA
VALN
Price
$5.38
$6.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$7.81
$15.50
AVG Volume (30 Days)
955.6K
78.6K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
242.86
N/A
EPS
N/A
N/A
Revenue
$197,141,000.00
N/A
Revenue This Year
$39.27
N/A
Revenue Next Year
$8.52
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.85
$4.75
52 Week High
$6.50
$12.23

Technical Indicators

Market Signals
Indicator
SRTA
VALN
Relative Strength Index (RSI) 40.74 59.79
Support Level $5.23 $5.03
Resistance Level $5.55 $6.60
Average True Range (ATR) 0.24 0.24
MACD -0.07 -0.05
Stochastic Oscillator 2.51 57.53

Price Performance

Historical Comparison
SRTA
VALN

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: